Mostrar el registro sencillo del ítem

dc.contributor.authorMorales, Kevin
dc.contributor.authorRodríguez Diéguez, Antonio 
dc.date.accessioned2022-06-22T07:32:29Z
dc.date.available2022-06-22T07:32:29Z
dc.date.issued2022-05-06
dc.identifier.citationInorg. Chem. 2022, 61, 7729−7745. [https://doi.org/10.1021/acs.inorgchem.1c03957]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/75591
dc.description.abstractThe synthesis, full characterization, photochemical properties, and cytotoxic activity toward cisplatin-resistant cancer cell lines of new semisquaraine-type Pt(II) complexes are presented. The synthesis of eight semisquaraine-type ligands has been carried out by means of an innovative, straightforward methodology. A thorough structural NMR and X-ray diffraction analysis of the new ligands and complexes has been done. Density functional theory calculations have allowed to assign the trans configuration of the platinum center. Through the structural modification of the ligands, it has been possible to synthesize some complexes, which have turned out to be photoactive at wavelengths that allow their activation in cell cultures and, importantly, two of them show remarkable solubility in biological media. Photodegradation processes have been studied in depth, including the structural identification of photoproducts, thus justifying the changes observed after irradiation. From biological assessment, complexes C7 and C8 have been demonstrated to behave as promising photoactivatable compounds in the assayed cancer cell lines. Upon photoactivation, both complexes are capable of inducing a higher cytotoxic effect on the tested cells compared with nonphotoactivated compounds. Among the observed results, it is remarkable to note that C7 showed a PI > 50 in HeLa cells, and C8 showed a PI > 40 in A2780 cells, being also effective over cisplatin-resistant A2780cis cells (PI = 7 and PI = 4, respectively). The mechanism of action of these complexes has been studied, revealing that these photoactivated platinum complexes would actually present a combined mode of action, a therapeutically potential advantage.es_ES
dc.description.sponsorshipInstituto de Salud Carlos IIIes_ES
dc.description.sponsorshipSpanish Government RTI2018-098027-B-C22es_ES
dc.description.sponsorshipEuropean Commission BIO2015-67358-C2-2-P CTQ2016-75363-Res_ES
dc.description.sponsorshipSpanish Government Instituto de Salud Carlos III Spanish Governmentes_ES
dc.description.sponsorshipGeneralitat de Catalunya 2017SGR-864es_ES
dc.language.isoenges_ES
dc.publisherAmerican Chemical Societyes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.titleSynthesis and In Vitro Studies of Photoactivatable Semisquarainetype Pt(II) Complexeses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1021/acs.inorgchem.1c03957
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España